Bryologyx
Dr. Deeks has been engaged in HIV care and clinical programs since 1993. He is an expert on HIV-associated immune dysfunction and its impact on HIV persistence and health during antiretroviral therapy. He is an author on more than 400 publications.
This person is not in the org chart
This person is not in any offices
Bryologyx
BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.